Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
暂无分享,去创建一个
John H Livingston | Roberta Battini | Ivana Olivieri | Enrico Bertini | Simon C Lovell | Adeline Vanderver | Jonathan E. Dickerson | Tiong Y Tan | Prab Prabhakar | E. Bertini | A. Vanderver | Alison M. Male | S. Lovell | Y. Crow | S. Bhaskar | C. Bacino | W. Marques | R. Battini | S. Orcesi | Jean-Pierre Lin | M. O’Connell | P. Lebon | G. Rice | T. Briggs | I. Desguerre | F. Rozenberg | L. Brueton | E. Wassmer | P. Mclaughlin | L. Keegan | E. Fazzi | P. Prabhakar | E. Wakeling | Tamio Suzuki | Johanna L Schmidt | P. Lonlay | C. Mignot | K. Steindl | Pierre Lebon | Yanick J Crow | Jonathan E Dickerson | Gabriella M. A. Forte | M. Szynkiewicz | I. Olivieri | A. Heiberg | Elisa Fazzi | P. Brogan | Àngels Garcia-Cazorla | Sanjeev S Bhaskar | J. Livingston | Cyril Mignot | Ram Kumar | T. Tan | Mary A O'Connell | Liam P Keegan | Pascale de Lonlay | Elizabeth Whittaker | Flore Rozenberg | Niamh M. Mannion | Sam M Greenwood | Carlos A Bacino | Isabelle Desguerre | R. Robinson | E. Whittaker | Katharina Steindl | Wilson Marques | M. Kawaguchi | Paul A Brogan | Arvid Heiberg | Evangeline Wassmer | Gillian I Rice | Paul R Kasher | Gabriella M A Forte | Niamh M Mannion | Marcin Szynkiewicz | Massimiliano Zampini | Tracy A Briggs | Emma M Jenkinson | Louise A Brueton | Marialuisa Carpanelli | Corinne De Laet | Mireia del Toro | Masakazu Kawaguchi | Ram Kumar | Jean-Pierre S-M Lin | Charles M Lourenco | Alison M Male | Simona Orcesi | Magnhild Rasmussen | Robert A Robinson | William G van der Merwe | Grace Vassallo | Emma L Wakeling | Tamio Suzuki | Paul J McLaughlin | G. Vassallo | E. Jenkinson | M. Zampini | P. Kasher | Charles M Lourenço | M. Rasmussen | C. Laet | M. Toro | M. Carpanelli | À. García-Cazorla | W. V. D. Merwe | T. Tan
[1] M. O’Connell,et al. An ADAR that edits transcripts encoding ion channel subunits functions as a dimer , 2003, The EMBO journal.
[2] G. Verdine,et al. Crystal structure of Staphylococcus aureus tRNA adenosine deaminase TadA in complex with RNA , 2006, Nature Structural &Molecular Biology.
[3] Yihong Yao,et al. Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus , 2009, Human genomics and proteomics : HGP.
[4] Geoff Kelly,et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase , 2011, Nature.
[5] Y. Crow. Type I interferonopathies: a novel set of inborn errors of immunity , 2011, Annals of the New York Academy of Sciences.
[6] J. Aicardi,et al. Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy , 1988, Journal of the Neurological Sciences.
[7] Vincent B. Chen,et al. KING (Kinemage, Next Generation): A versatile interactive molecular and scientific visualization program , 2009, Protein science : a publication of the Protein Society.
[8] Tamio Suzuki,et al. Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria. , 2003, American journal of human genetics.
[9] M. Komine,et al. Six novel mutations of the ADAR1 gene in patients with dyschromatosis symmetrica hereditaria: Histological observation and comparison of genotypes and clinical phenotypes , 2008, The Journal of dermatology.
[10] Alexander Rich,et al. Widespread A-to-I RNA Editing of Alu-Containing mRNAs in the Human Transcriptome , 2004, PLoS biology.
[11] M. O’Connell,et al. Editing independent effects of ADARs on the miRNA/siRNA pathways , 2009, The EMBO journal.
[12] B. Bass,et al. Inositol Hexakisphosphate Is Bound in the ADAR2 Core and Required for RNA Editing , 2005, Science.
[13] C. Samuel,et al. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Washburn,et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein , 2011, Nature.
[15] D. Stetson,et al. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. , 2012, Immunity.
[16] D. Wieczorek,et al. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome. , 2010, Arthritis and rheumatism.
[17] S. Orkin,et al. Corrigendum: ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling , 2009, Nature Immunology.
[18] Baek Kim,et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates , 2012, Nature Immunology.
[19] Y. Crow,et al. Aicardi‐Goutières syndrome: an important Mendelian mimic of congenital infection , 2008, Developmental medicine and child neurology.
[20] Frédéric H.-T. Allain,et al. The Solution Structure of the ADAR2 dsRBM-RNA Complex Reveals a Sequence-Specific Readout of the Minor Groove , 2010, Cell.
[21] John M. Murray,et al. Requirement of Dimerization for RNA Editing Activity of Adenosine Deaminases Acting on RNA* , 2003, The Journal of Biological Chemistry.
[22] A. Rich,et al. Crystal structure of the Zalpha domain of the human editing enzyme ADAR1 bound to left-handed Z-DNA. , 1999, Science.
[23] S. Greenberg,et al. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway , 2011, Annals of the rheumatic diseases.
[24] Y. Crow,et al. Chilblains as a diagnostic sign of aicardi-goutières syndrome. , 2010, Neuropediatrics.
[25] B. Bass,et al. Adar Editing in Double-stranded Utrs and Other Noncoding Rna Sequences , 2022 .
[26] M. Wabl,et al. An autoimmune disease prevented by anti-retroviral drugs , 2011, Retrovirology.
[27] D. Barnes,et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. , 2007, American journal of human genetics.
[28] T. Heidmann,et al. Trex1 Prevents Cell-Intrinsic Initiation of Autoimmunity , 2008, Cell.
[29] M. O’Connell,et al. RNA editing by mammalian ADARs. , 2011, Advances in genetics.
[30] M. Zalis,et al. Visualizing and quantifying molecular goodness-of-fit: small-probe contact dots with explicit hydrogen atoms. , 1999, Journal of molecular biology.
[31] T. Hashimoto,et al. Dystonia, mental deterioration, and dyschromatosis symmetrica hereditaria in a family with ADAR1 mutation , 2006, Movement disorders : official journal of the Movement Disorder Society.
[32] D. Barnes,et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus , 2006, Nature Genetics.
[33] A. Green,et al. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. , 2007, American journal of human genetics.
[34] T. Matise,et al. Widespread RNA editing of embedded alu elements in the human transcriptome. , 2004, Genome research.
[35] Yong-Jun Kwon,et al. Automated Genome-Wide Visual Profiling of Cellular Proteins Involved in HIV Infection , 2011, Journal of biomolecular screening.
[36] C. Ponting,et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection , 2006, Nature Genetics.
[37] Zipora Y. Fligelman,et al. Systematic identification of abundant A-to-I editing sites in the human transcriptome , 2004, Nature Biotechnology.
[38] Ayelet T. Lamm,et al. Competition between ADAR and RNAi pathways for an extensive class of RNA targets , 2011, Nature Structural &Molecular Biology.
[39] K. Nishikura,et al. ADAR1 RNA Deaminase Limits Short Interfering RNA Efficacy in Mammalian Cells* , 2005, Journal of Biological Chemistry.
[40] J. Richardson,et al. The penultimate rotamer library , 2000, Proteins.
[41] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[42] Guolong Zhang,et al. Mutational spectrum of the ADAR1 gene in dyschromatosis symmetrica hereditaria , 2010, Archives of Dermatological Research.
[43] Y. Crow,et al. A de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi–Goutières syndrome , 2010, American journal of medical genetics. Part A.
[44] Jonathan C. Fuller,et al. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response , 2009, Nature Genetics.
[45] I. Mian,et al. A Z-DNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Lieberman,et al. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1 , 2010 .
[47] Richard Wooster,et al. A survey of RNA editing in human brain. , 2004, Genome research.
[48] J. Richardson,et al. Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation. , 1999, Journal of molecular biology.
[49] Patrice Vitali,et al. dsRNAs containing multiple IU pairs are sufficient to suppress interferon induction and apoptosis , 2013 .
[50] B. Sobhian,et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx , 2011, Nature.
[51] T. Negoro,et al. Dyschromatosis symmetrica hereditaria associated with neurological disorders , 2008, The Journal of dermatology.
[52] Rodrigo Lopez,et al. Clustal W and Clustal X version 2.0 , 2007, Bioinform..